This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
By assigning every dollar a job, zero based budgeting reveals waste and prioritizes essential expenses, accelerating savings and debt payoff.
28,071 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
Amazon stock is drawing renewed investor attention as AI monetization and AWS growth accelerate. A fresh price predic...
Europe's quest for cheaper inputs produced resilience gaps. Leaders now pivot to redundancy and security, risking hig...
Walmart and Costco together account for about 28.7% of XLP’s assets, tightening concentration and raising questions a...
As XRP tests new volatility, investors debate shocking ripple price predictions that span from modest gains to outsiz...
In a dividend aristocrats shaky market, Coca-Cola, Procter & Gamble, Johnson & Johnson, McDonald's, and Colgate-Palmo...
Gas prices are edging higher in March 2026 as geopolitical tensions lift crude costs. A new chart breaks down the pri...
Friday marks the first triple witching of 2026 as Iran tensions flare, prompting investors to brace for volatile move...
CrowdStrike delivered a solid ARR beat but guided below lofty expectations, triggering a about 7% drop in CRWD shares...
The S&P 500 reached a new record as Bitcoin faced renewed selling pressure. Analysts say the divide underscores a liq...
Ethereum retreats from a rough start to the year, but a key analyst says Crypto Spring has begun. Investors are watch...